Novo wins FDA approval for high-dose Wegovy under commissioner’s vouchernews2026-03-19T18:06:03+00:00March 19th, 2026|Endpoints News|
CSL says its hemophilia B gene therapy is out of stocknews2026-03-19T16:33:06+00:00March 19th, 2026|Endpoints News|
Collegium is acquiring Corium’s approved ADHD drug for $650Mnews2026-03-19T14:55:37+00:00March 19th, 2026|Endpoints News|
Pfizer seeks earlier use of Talzenna in prostate cancer with Phase 3 winnews2026-03-19T14:24:11+00:00March 19th, 2026|Endpoints News|
Updated: Lilly’s triple-G comparable with Mounjaro, first Phase 3 diabetes data suggestnews2026-03-19T10:45:27+00:00March 19th, 2026|Endpoints News|
Lawmakers signal willingness to counter China’s biotech gainsnews2026-03-18T19:41:47+00:00March 18th, 2026|Endpoints News|
Sanofi, AbbVie, Novartis and AstraZeneca face revived 340B pricing casenews2026-03-18T19:34:40+00:00March 18th, 2026|Endpoints News|
FDA opens door to RMAT designations for therapies on clinical holdnews2026-03-18T18:54:41+00:00March 18th, 2026|Endpoints News|
FDA approves J&J’s psoriasis pill Icotyde with $5B+ peak sales potentialnews2026-03-18T13:39:56+00:00March 18th, 2026|Endpoints News|
Aspen’s personalized Parkinson’s therapy shows early promisenews2026-03-18T13:00:44+00:00March 18th, 2026|Endpoints News|
